ElliotStephenBarnathanMDFACC
Cardiology • Havertown, PASenior Director, Janssen Research and Development LLC
Dr. Barnathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1734 Ridgeway Rd
Havertown, PA 19083Phone+1 610-574-1049
Education & Training
Perelman School of Medicine at the University of PennsylvaniaClass of 1981
Certifications & Licensure
PA State Medical License 1982 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
- PharmaVoice100 Inspiring Leader 2020 PharmaVoice https://www.pharmavoice.com/digital-edition/july-august-2020#108, 2020
Clinical Trials
- A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients Start of enrollment: 2014 Jan 07
- A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection Start of enrollment: 2020 Aug 13
Publications & Presentations
PubMed
- 287 citationsEmbolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysisPaul T. Vaitkus, Elliot S. Barnathan
Journal of the American College of Cardiology. 1993-10-01 - 31 citationsRationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study.Warren H. Capell, Elliot S. Barnathan, Gregory Piazza, Alex C. Spyropoulos, Judith Hsia
American Heart Journal. 2021-02-09 - 86 citationsModified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended ThromboprophylaxisAlex C. Spyropoulos, Concetta Lipardi, Jianfeng Xu, Colleen Peluso, Theodore E. Spiro
TH Open. 2020-03-13
Abstracts/Posters
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan TrialElliot S. Barnathan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan TrialElliot S. Barnathan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner StudiesElliot S. Barnathan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The World Association of Sarcoidosis and Other Granulomatous Disorders North American Conference 2012Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Cleveland, Ohio - 10/4/2012
Press Mentions
Penn Scientists Win $3 Million Prize for Research That Enabled COVID-19 VaccinesSeptember 9th, 2021- A One-Way Ticket. A Cash-Stuffed Teddy Bear. A Dream Decades in the MakingAugust 19th, 2021
- An Interview with Manuel and Ann Varela: Who Is Katalin Karikó?May 17th, 2021
- Join now to see all
Grant Support
- Vascular Injury Response--Novel Mechanisms And TherapyNational Heart, Lung, And Blood Institute1995
- Endothelial Cell Plasminogen Activator ReceptorsNational Heart, Lung, And Blood Institute1990–1994
- Plasminogen Activator Regulation During RestenosisNational Heart, Lung, And Blood Institute1991–1993
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
